1. Summary of clinically diagnosed amniotic fluid embolism cases in Korea and disagreement with 4 criteria proposed for research purpose
- Author
-
Hyun Mee Ryu, Cheong-Rae Roh, Won Joon Seong, Soo-young Oh, Hyun Joo Seol, Jeong In Yang, Ji Hee Sung, Jin ha Kim, Joon Seok Hong, Suk-Joo Choi, and Jin Gon Bae
- Subjects
medicine.medical_specialty ,Pediatrics ,Referral ,diagnosis ,korea ,Research purpose ,lcsh:Gynecology and obstetrics ,Maternal-Fetal Medicine ,Maternal-fetal medicine ,03 medical and health sciences ,Amniotic fluid embolism ,0302 clinical medicine ,Coagulopathy ,medicine ,Survival rate ,lcsh:RG1-991 ,Disseminated intravascular coagulation ,030219 obstetrics & reproductive medicine ,criteria ,business.industry ,Obstetrics and Gynecology ,medicine.disease ,amniotic fluid embolism ,030220 oncology & carcinogenesis ,Clinical diagnosis ,Original Article ,business - Abstract
Objective This study aimed 1) to investigate the clinical characteristics of amniotic fluid embolism (AFE) cases clinically diagnosed by maternal fetal medicine (MFM) specialists in Korea, 2) to check the disagreement with 4 recently proposed criteria by the Society for Maternal-Fetal Medicine (SMFM) for research purpose, and 3) to compare maternal outcomes between cases satisfying all 4 criteria and cases with at least 1 missing criterion. Methods This study included 12 patients clinically diagnosed with AFE from 7 referral hospitals in Korea. We collected information, including maternal age, symptoms of AFE, the amount of transfusion, and maternal mortality. Results The median maternal age was 33 years (range, 28–40 years). Regarding symptoms, cardiovascular arrest, hypotension, respiratory compromise, clinical coagulopathy, and neurologic signs were observed in 41.7%, 83.3%, 83.3%, 100%, and 66.7% of the cases, respectively. Among the 12 cases, 5 women died and 2 suffered severe neurologic disability, showing an intact survival rate of 41.7%. Disagreement with all 4 criteria proposed by the SMFM was found in 66.7% of the cases, due to the lack of criteria for disseminated intravascular coagulation or strict onset time (
- Published
- 2021
- Full Text
- View/download PDF